Anthony M. Manning's most recent trade in Monte Rosa Therapeutics Inc was a trade of 10,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 29, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics Inc | Dr. Anthony M. Manning, PhD | Director | 29 Jun 2026 | 10,000 | 2,100 | - | - | Stock Option (Right to Buy) | ||
| Monte Rosa Therapeutics Inc | Dr. Anthony M. Manning, PhD | Director | Sale of securities on an exchange or to another person at price $ 23.11 per share. | 29 Jun 2026 | 10,000 | 0 | - | 23.1 | 231,100 | Common Stock |
| Monte Rosa Therapeutics Inc | Dr. Anthony M. Manning, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.16 per share. | 29 Jun 2026 | 10,000 | 10,000 | - | 4.2 | 41,600 | Common Stock |
| Monte Rosa Therapeutics Inc | Dr. Anthony M. Manning, PhD | Director | 11 Jun 2026 | 25,800 | 25,800 | - | - | Stock Option (Right to Buy) | ||
| Monte Rosa Therapeutics Inc | Dr. Anthony M. Manning, PhD | Director | 21 May 2026 | 10,000 | 12,100 | - | - | Stock Option (Right to Buy) | ||
| Monte Rosa Therapeutics Inc | Dr. Anthony M. Manning, PhD | Director | Sale of securities on an exchange or to another person at price $ 18.01 per share. | 21 May 2026 | 10,000 | 0 | - | 18.0 | 180,100 | Common Stock |
| Monte Rosa Therapeutics Inc | Dr. Anthony M. Manning, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.16 per share. | 21 May 2026 | 10,000 | 10,000 | - | 4.2 | 41,600 | Common Stock |
| Monte Rosa Therapeutics Inc | Dr. Anthony M. Manning, PhD | Director | 13 Jun 2025 | 30,700 | 30,700 | - | - | Stock Option (Right to Buy) | ||
| Palatin Technologies Inc | Dr. Anthony M. Manning, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 12,000 | 36,080 (0%) | 0% | 0 | - | |
| Monte Rosa Therapeutics Inc | Dr. Anthony M. Manning, PhD | Director | 12 Jun 2024 | 22,100 | 22,100 | - | - | Stock Option (Right to Buy) | ||
| Monte Rosa Therapeutics Inc | Dr. Anthony M. Manning, PhD | Director | 25 Jul 2023 | 41,000 | 41,000 | - | - | Stock Option (Right to Buy) | ||
| Palatin Technologies Inc | Dr. Anthony M. Manning, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 10,000 | 36,693 (0%) | 0% | 0 | - | |
| Palatin Technologies Inc | Dr. Anthony M. Manning, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 73,000 | 693,667 (0%) | 0% | 0 | - |